| 000 | 01774 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516173218.0 | ||
| 264 | 0 | _c20140616 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0076009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCyran, Clemens C | |
| 245 | 0 | 0 |
_aRegorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation. _h[electronic resource] |
| 260 |
_bPloS one _c2013 |
||
| 300 |
_ae76009 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeterografts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 |
_aMicrocirculation _xdrug effects |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 700 | 1 | _aKazmierczak, Philipp M | |
| 700 | 1 | _aHirner, Heidrun | |
| 700 | 1 | _aMoser, Matthias | |
| 700 | 1 | _aIngrisch, Michael | |
| 700 | 1 | _aHavla, Lukas | |
| 700 | 1 | _aMichels, Alexandra | |
| 700 | 1 | _aEschbach, Ralf | |
| 700 | 1 | _aSchwarz, Bettina | |
| 700 | 1 | _aReiser, Maximilian F | |
| 700 | 1 | _aBruns, Christiane J | |
| 700 | 1 | _aNikolaou, Konstantin | |
| 773 | 0 |
_tPloS one _gvol. 8 _gno. 9 _gp. e76009 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0076009 _zAvailable from publisher's website |
| 999 |
_c23145787 _d23145787 |
||